Discipline, Fall 2020

Discipline Decisions (Fall 2020)

Discipline Decisions banner
Share this:

Maria Musitano (OCP #108758)

At a hearing on July 20, 2020 a Panel of the Discipline Committee made findings of professional misconduct against Maria Musitano in that she:

READ MORE
  • Sold and/or dispensed certain identified prescription drugs to the patient, [Patient], without lawful or otherwise valid prescriptions;
  • Failed to keep records as required regarding certain identified prescription drugs dispensed to the patient, [Patient];
  • Falsified records regarding certain identified prescription drugs dispensed to the patient, [Patient]; and/or
  • Contravened the OCP policy on Prescriptions – Out of Country, dated January-February 2003, with respect to entering into an agreement or otherwise facilitating the practice of Dr. [Name] to re-issue prescriptions for the patient, [Patient], despite not having any substantive professional relationship with the patient, in relation to certain identified transactions.

In particular, the Panel found that the Member:

  • Failed to maintain a standard of practice of the profession;
  • Failed to provide an appropriate level of supervision to a person whom she was professionally obligated to supervise, including other pharmacist and non-pharmacist staff at the Pharmacy;
  • Failed to keep records as required respecting her patients (for conduct up to and including May 4, 2017), and/or respecting her patients or practice (for conduct on or after May 5, 2017);
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement (for conduct up to and including May 4, 2017), and/or that she knew or ought to have known contained a false or misleading statement (for conduct on or after May 5, 2017);
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular,
    • sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended,
    • sections 54, 55, 56 and/or 57 of Ontario Regulation 58/11, as amended, and/or
    • sections 20 and/or 21 of Ontario Regulation 264/16, as amended (for conduct up to and including May 4, 2017);
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
    • sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or
    • sections 20 and/or 21 of Ontario Regulation 264/16, as amended (for conduct on or after May 5, 2017);
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional.

The Panel imposed an Order, as follows:

  1. A reprimand;
  2. Directing the Registrar to impose the following specified terms, conditions or limitations on the Member’s certificate of registration, and in particular, requiring the Member to complete successfully, at her own expense and within twelve (12) months of the date of this Order the ProBE Program on Professional/Problem Based Ethics for Healthcare Professionals, with an unconditional pass, or provide evidence satisfactory to the College that she has completed this Program with an unconditional pass within the 12 months prior to the date of this Order;
  3. Directing the Registrar to suspend the Member’s Certificate of Registration for a period of four (4) months, with one (1) month of the suspension to be remitted on condition the Member complete the remedial training programs as specified in paragraph 2 above. The suspension shall commence on July 20, 2020 and continue without interruption until October 19, 2020. If the remitted portion of the suspension has to be served because the Member fails to complete the remedial training programs as specified in paragraph 2 above, the further suspension shall commence on July 20, 2021 and continue without interruption until August 19, 2021, unless the time for completing the remedial steps in paragraph 2 above is extended by the Registrar, in which case, the date the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly; and
  4. Costs to the College in the amount of $10,000.00.

In its reprimand, the Panel noted that pharmacy is a self-regulated profession. The practice of pharmacy is a privilege and it comes with significant obligations to the public, the profession, and oneself.

The Panel observed that the Member’s actions put the public at risk by dispensing prescription drugs without valid authorization, failing to keep records, and falsifying records. She contravened the Ontario College of Pharmacists policy on Prescriptions – Out of Country despite being aware of that policy. The Panel pointed out that the Member failed in her obligations as a pharmacist and a Designated Manager.

The Panel expressed its expectation that the Member will not appear again before a panel of the Discipline Committee of the Ontario College of Pharmacists.


George Politis (OCP #68632)

At a hearing on July 27, 2020, a Panel of the Discipline Committee made findings of professional misconduct against George Politis in that he:

READ MORE
  • Conducted MedsCheck At Home reviews that were not adequate, for multiple patients;
  • Failed to properly document MedsCheck At Home reviews, for multiple patients;
  • Submitted, or had staff submit, accounts or charges for services to the Ontario Drug Benefit program for MedsCheck At Home reviews that were non-compliant with the guidelines of the Ministry of Health and Long Term Care, including guidelines regarding timeliness of claims.

In particular, the Panel found that the Member:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients;
  • Engaged in conduct that, having regard to all the circumstances, would reasonably be regarded by members of the profession as dishonourable and unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;

2. That the Registrar be directed to impose the following conditions on the Member’s certificate of registration:

a. that, if the Member wishes to return to Part A of the register, the Member successfully complete, prior to the date the Member returns to Part A, a course with Gail E. Siskind Consulting Services, or another professional ethics consultant acceptable to the College, to be designed by the consultant, with the purpose of addressing the professional misconduct issues raised in this case; the following terms shall apply to the course:

i. the number of sessions shall be at the discretion of the consultant, but shall be a minimum of 2, and maximum of 3;

ii. the manner of attendance at the session(s) (e.g. in person, via Skype, etc.) is a matter to be discussed in advance between the Member and the consultant, but shall ultimately be at the discretion of the consultant;

iii. Successful completion of the course will include completion of an essay, acceptable to the Registrar, addressing the professional misconduct issues raised in this case;

iv. The essay shall be at least 1000 words in length. The Member shall be responsible for the cost of review by the consultant to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500;

v. the Member shall be responsible for the cost of the course;

vi. the Member will request a report from the consultant confirming that the Member has completed the course to the satisfaction of the consultant, and the Member will provide a copy of the report to the College prior to the date the Member returns to Part A;

b. that, if the Member returns to Part A of the register, the Member be prohibited from acting as a Designated Manager for any pharmacy, for a period of nine (9) months, commencing on the date the Member returns to Part A;

3. Directing the Registrar to suspend the Member’s Certificate of Registration for a period of 3 months. The suspension shall commence on July 28, 2020, and run until October 27, 2020, inclusive;

4. Costs to the College in the amount of $10,000.

In its reprimand, the Panel noted that pharmacy is a self-regulated profession, the practice of which is a privilege, and which comes with significant obligations to the public, the profession, and oneself.

The Panel observed that pharmacists have an obligation to act in the best interest of the public, and the Member’s actions put the public at risk. The Panel noted that there is an expectation that pharmacists perform due diligence while providing a MedsCheck for the patient. The Panel expressed its view that the Member’s actions are even more reprehensible in that he was dealing with a vulnerable patient population and yet he conducted non-compliant medication reviews. The Panel noted that the Member failed in his role to provide other healthcare professionals with accurate documentation that would ensure a high quality continuum of care.

The Panel relayed its expectation that, as a pharmacist, whether in Part A or B of the register, the Member’s actions always have the best interest of the public and patients as his priority, and that the Member will not appear before a discipline panel again in the future.


Chris Popoola (OCP #204452)

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Popoola committed professional misconduct in that she:

READ MORE
  • Failed to maintain personal professional liability insurance from approximately January 2016 to approximately March 24, 2019 while maintaining her registration in Part A of the Register;
  • Made false statements respecting her personal professional liability insurance when she renewed her registration in Part A of the Register on or about March 7, 2016, March 9, 2017, and March 9, 2018; and
  • Made false statements respecting her provision of at least 600 hours of patient care over the preceding three years while practising the profession of pharmacy when she renewed her registration in Part A of the Register on or about March 9, 2018 and April 8, 2019.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Signed or issued, in her professional capacity, documents that she knew and/or ought to have known contained false or misleading statements;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

The College brought a motion, on consent, before a Panel of the Discipline Committee to stay allegations of professional misconduct against Ms. Popoola. As part of the resolution of this matter, Ms. Popoola entered into an Acknowledgment and Undertaking by which she agreed to permanently resign as a member of the College, surrender irrevocably her Certificate of Registration, no longer engage in the practice of pharmacy in Ontario, and no longer work or be employed in a pharmacy in any capacity.

On July 31, 2020, a panel of the Discipline Committee accepted the joint submission of the parties and issued an Order staying the allegations of professional misconduct against Ms. Popoola, and ordered that the stay shall remain in effect unless and until Ms. Popoola applies for reinstatement of her certificate of registration.


Ashit Shihora (OCP #109452)

At a hearing on August 4, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Ashit Shihora in that during the period March 8, 2018 to July 3, 2019, while his certificate of registration was suspended pursuant to an interim order of the Inquiries, Complaints and Reports Committee, he:

READ MORE
  • Used the title “pharmacist” and/or held himself out as a person who is qualified to practice in Ontario as a pharmacist;
  • Operated a pharmacy while it was not under the supervision of a pharmacist who was physically present;
  • Was employed or worked in the pharmacy or otherwise engaged in the practice of pharmacy;
  • Compounded, dispensed and/or sold a drug;
  • Directed pharmacists and/or staff to bill the Ontario Drug Benefit Program for pharmaceutical opinions when he knew or ought to have known that they were not eligible for a professional services fee; and/or
  • Managed and/or directed pharmacists and/or staff.

In particular, the Panel found that he:

  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act R.S.O. 1990, c.H. 4, as amended, the Regulated Health Professions Act, 1991 S.O. 1991, c. 18, as amended, or the regulations under those Acts, and in particular,
    • ss. 10.(1) and/or ss. 10.(2) of the Pharmacy Act;
    • s. 143 and/or s.149 of the Drug and Pharmacies Regulation Act,
    • s. 27 of the Regulated Health Professions Act, 1991, with respect; and/or
    • s. 146 of the Drug and Pharmacies Regulation Act;
  • Failed to comply with an interim order;
  • Practiced the profession while his certificate of registration was suspended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional.

The Panel imposed an Order as follows:

  1. A reprimand;
  2. Directing the Registrar to revoke Mr. Shihora’s Certificate of Registration;
  3. Costs to the College in the amount of $12,000.

In its reprimand, the Panel noted that pharmacy is a self-regulated profession; pharmacists have a responsibility to ensure that the public is adequately protected and to maintain the public’s confidence in their ability to govern themselves.

The Panel observed that Mr. Shihora failed to maintain the responsibilities and obligations expected of him as a member of the profession. He failed in his professional and legal obligations, and he failed to adhere to the laws and regulations that govern the profession.

He engaged in conduct that reflects poorly on himself and the profession.

The Panel expressed its view that the revocation of Mr. Shihora’s Certificate of Registration will serve to protect the public.

The Panel relayed its hope that this proceeding provides Mr. Shihora with an opportunity to reflect and pursue a new path forward.


Hussain (Azouz) Al-Yasery (OCP #607011)

At a hearing in writing held on August 13, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Hussain (Azouz) Al-Yasery with respect to the following incidents:

READ MORE
  • He engaged in three assaults, each of which is an offence contrary to section 266 of the Criminal Code, and in the conduct and acts which form the basis of those criminal convictions;
  • On or about October 10, 2018, he was found guilty of three counts of assault, each of which is an offence contrary to section 266 of the Criminal Code;
  • He failed to report to the Registrar within 30 days the details of charges against him under the Criminal Code, as set out in informations sworn on or about July 16, 2017, September 8, 2017, September 21, 2017, and/or October 19, 2017, as required by College By-Law No. 4, Article 12.1.3.

In particular, the Panel found that the Member:

  • Was found guilty of an offence that is relevant to his suitability to practice;
  • Contravened a term, condition or limitation imposed on his certificate of registration, pursuant to section 5, paragraph (1)ii of Ontario Regulation 202/94;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional.

The Panel imposed an Order as follows:

1. A reprimand;

2. That the Registrar is directed to impose specified terms, conditions or limitations on the Member’s Certificate of Registration, and in particular: that he successfully complete, within six (6) months of the date that this Order becomes final, a course with Gail E. Siskind Consulting Services, or another professional ethics consultant chosen by the College, to be designed by the consultant, but with the general aim of addressing the issues raised in this matter, including personal conduct (in relation to the assaults) and the responsibilities of a regulated health professional (in relation to the failure to report the charges to the College as required).

The following terms shall apply to the course:

a. The number of sessions shall be at the discretion of the consultant, but shall be no fewer than one (1).

b. The manner of attendance at the session(s) (e.g. in person, via Skype, etc.) is a matter to be discussed in advance between the Member and the consultant, but shall ultimately be at the discretion of the consultant.

c. The Member shall be responsible for the cost of the course.

d. Successful completion of the course will include completion of an essay, acceptable to the Registrar, addressing the issues raised in this matter, including boundaries and the responsibilities of a regulated health professional.

e. The essay shall be at least 1000 words in length. The Member shall be responsible for the cost of review by the consultant to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500.

3. That the Registrar suspend the Member’s Certificate of Registration for a period of two (2) months, with one (1) month of the suspension to be remitted on condition that the Member complete the remedial training as specified in paragraph 2. The suspension shall commence on the date that this Order becomes final, and shall continue for one (1) month, inclusive. If the remitted portion of the suspension is required to be served by the Member because he fails to complete the remedial requirement specified in paragraph 2, that portion of the suspension shall commence on the date that is six (6) months from the date that this Order becomes final, and shall continue for one (1) month, inclusive. If the time for completing the remedial steps in paragraph 2, above, is extended by the Registrar, the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $6,500.

In its reprimand, the Panel related that it was deeply troubled by the facts presented. The Panel noted that the Member’s conduct is inexcusable and unacceptable in the eyes of both the public and the profession.

The Panel observed that the practice of Pharmacy is a privilege that carries significant obligations to the public, the profession, and oneself. The result of the Member’s professional misconduct is that he has eroded the public trust in the pharmacy profession and cast a shadow over his suitability to practice as a pharmacist.

Members of the public and patients hold the pharmacy profession in high regard. As such, it is expected that pharmacists conduct themselves with the highest degree of professionalism and respect. The Panel observed that the Member failed to maintain the responsibilities and obligations expected of him as a member of this profession. He admitted to, and was found guilty of, three criminal offences. Most troubling, he caused harm to others.

The Panel noted that the suspension of the Member’s Certificate of Registration and the remediation requirements are essential to protect the public and maintain the honour of the profession. It is the Panel’s expectation that the Member will not appear again before a panel of the Discipline Committee of the Ontario College of Pharmacists.


Maged Ghobrial (OCP #613350)

At a hearing on September 25, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Maged Ghobrial in that he:

READ MORE
  • Submitted false or unsubstantiated claims for medications and/or health supplies not requested by and/or not dispensed to certain identified patients; and/or
  • Created false records in relation to claiming for medications and/or health supplies not requested by and/or dispensed to certain identified patients.

In particular, the Panel found that he:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services and/or products that he knew and/or ought to have known was false or misleading;
  • Charged a fee and/or amount that was excessive in relation to the service and/or product provided; and/or
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;

2. Directing the Registrar to impose the following specified terms, conditions or limitations on the Member’s certificate of registration, and in particular,

a. Requiring the Member to complete successfully, at his own expense and within twelve (12) months of the date of this Order, the ProBE Program on Professional/Problem Based Ethics for Healthcare Professionals, with an unconditional pass, or to provide evidence satisfactory to the College that he has completed this program and any related evaluations within the (twelve) 12 month period prior to the date of this Order.

b. Restricting the Member from being the Designated Manager at any pharmacy for a period of two (2) years from the date of this Order.

c. Requiring the Member to complete a mentorship program within six (6) months of resuming responsibilities as a Designated Manager at any pharmacy, after the restriction in subparagraph (b) above has expired, with the Member to:

i. retain, at the Member’s expense, a practice mentor acceptable to the College, within one (1) month of the date on which the Member advises the College that he intends to act as the Designated Manager of a pharmacy in Ontario;

ii. meet at least three (3) times with the practice mentor for the purpose of reviewing the Member’s practice and identifying areas in the Member’s practice as a Designated Manager that require remediation; to this end, the Member shall provide the practice mentor with the following documents related to this proceeding:

1. a copy of the Notice of Hearing;

2. a copy of the Agreed Statement of Facts;

3. a copy of the Joint Submission on Order;

4. a copy of the Decision and Reasons, when available; and/or

5. a copy of the Order, if applicable and when available;

iii. develop a learning plan to address the areas requiring remediation;

iv. demonstrate to the practice mentor that the Member has achieved progress in meeting the goals established in the learning plan;

v. require the practice mentor to report the results of the mentorship meetings to the Manager, Conduct Operations, at the College, after their completion, which shall be no later than six (6) months from the date that the Member resumes the duties of the Designated Manager at any pharmacy.

3. Directing the Registrar to suspend the Member’s Certificate of Registration for a period of five (5) months, with one (1) month of the suspension to be remitted on condition the Member complete the remedial training program as specified in paragraph 2(a) above. The suspension shall commence on September 25, 2020 and continue without interruption until January 24, 2021, inclusive. If the remitted portion of the suspension has to be served because the Member fails to complete the remedial training program as specified in paragraph 2(a) above, the further suspension shall commence on September 25, 2021 and continue without interruption until October 24, 2021, inclusive, unless the time for completing the remedial steps in paragraph 2(a) above is extended by the Registrar, in which case, the date the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $10,000.00

In its reprimand, the Panel noted that Mr. Ghobrial is a member of the highly respected profession of Pharmacy. Integrity and trust are paramount to his profession, as he provides care to the public. In return, pharmacists are held in high regard for the role played in the provision of healthcare in Ontario.

This Panel expressed its extreme disappointment with Mr. Ghobrial’s actions and his appearance before the Discipline Committee for the second time, the first appearance being nine months earlier in January 2020.

The Panel noted that it is a privilege and not a right to practice pharmacy. The Panel voiced its expectation that Mr. Ghobrial will learn from this process, that he will improve his practice of pharmacy, and that he will work hard to regain the trust he has lost through his misconduct.

The Panel related its expectation that Mr. Ghobrial will practice with personal and professional integrity and that he will never appear before a panel of the Discipline Committee again.


Ewa Polak (OCP #207848)

At a hearing on September 29, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Ewa Polak, in that she:

READ MORE
  • Failed to exercise appropriate professional diligence with respect to the dispensing of narcotics, which resulted in her filling forged prescriptions purportedly written by Dr. [Name] without making appropriate inquiries;
  • Failed to exercise appropriate professional diligence with respect to the dispensing of narcotics, which resulted in her filling prescriptions for Oxycodone CR 40 and 80mg in doses and/or quantities that were clinically questionable, without taking or documenting any steps to assess the propriety of the prescription.

In particular, the Panel found that Ms. Polak:

  • Failed to maintain a standard of practice of the profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or section 40 of O.Reg. 58/11, R.S.O. 1990, c.H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;

2. That the Registrar is directed to impose specified terms, conditions or limitations on the Member’s certificate of registration, and in particular:

a. That the Member complete an ethics course with Dr. Erika Abner, or another professional ethics consultant chosen by the College, to be designed by the consultant, for the purpose of addressing the professional and ethical obligations arising in the Member’s case, within 12 months of the date of this Order. The following terms shall apply to the course:

i. the number of sessions shall be at the discretion of the consultant, but shall be at least two meetings;

ii. the manner of attendance at the session(s) (e.g. in person, via Skype, etc.) is a matter to be discussed in advance between the Member and the consultant, but shall ultimately be at the discretion of the consultant;

iii. The Member shall be responsible for the cost of the course;

iv. the Member shall provide to the consultant, in advance of the course, a copy of the Agreed Statement of Facts tendered before the Panel in this hearing;

v. Successful completion of the course will include completion of an essay, acceptable to the Registrar, addressing the ethical issues raised in this matter regarding opioid dispensing;

vi. The essay shall be at least 1000 words in length. The Member shall be responsible for the cost of review by the consultant to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500;

vii. the Member will request a report from the consultant confirming that the Member has completed the course to the satisfaction of the consultant, and the Member will provide a copy of the report and the essay referred to above to the College within 12 months of the date of this Order.

b. That the Member complete successfully, at her own expense, within twelve months of the date of this Order, the Safe and Effective Use of Opioids for Chronic Non-cancer Pain, offered by the Centre for Addiction and Mental Health.

c. That the Member shall be prohibited, for a period of three years from the date of this Order, from acting as a Designated Manager or narcotic signer at any pharmacy.

3. That the Registrar is directed to suspend the Member’s Certificate of Registration for a period of six months with one month of the suspension be remitted on condition that the Member complete the remedial training as specified in subparagraphs 2(a) and 2(b). The suspension shall commence on September 30, 2020 and shall continue until February 28, 2021, inclusive. If the remitted portion of the suspension is required to be served by the Member because she fails to complete the remedial training as specified in subparagraphs 2(a) and/or 2(b), that portion of the suspension shall commence on March 1, 2022, and shall continue until March 31, 2022, inclusive, unless the time for completing the remedial training in subparagraphs 2(a) and/or 2(b), above is extended by the Registrar, in which case, the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $10,000.

In its reprimand, the Panel noted that Ms. Polak is a member of the highly respected profession of pharmacy. Practice standards require safe and secure management of narcotic and controlled substances. These practice standards are designed to prevent misuse, abuse, and diversion of the substances that are regulated due to their high potential for addiction.

The Panel acknowledged Ms. Polak’s efforts in cooperating with the College throughout this process and in taking some initial steps towards improvements; however, the Panel observed that, as a Designated Manager, her actions lacked adherence to the standards of practice, and her failure to recognise red flags cannot be ignored. The Panel noted that, as the dispensing pharmacist, Ms. Polak’s actions and failure to follow the College’s guidelines regarding the identification of forgeries and fraudulent prescriptions are particularly alarming.

The Panel relayed its expectation that Ms. Polak will take the necessary steps to improve her practice standards to reduce the risk of these events reoccurring in the future, and expressed its trust that Ms. Polak will not return before a panel of the Discipline Committee again.


Donghyun (Tony) Kim (OCP #625722)

At a hearing on October 5, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Donghyun (Tony) Kim, in that he:

READ MORE
  • Stole grocery merchandise from Sobeys in Oshawa, Ontario, on or about January 27, 2019, and/or on about January 28, 2019, and/or on or about January 30, 2019, and/or on or about January 31, 2019, and/or on about February 6, 2019.

In particular, the Panel found that he:

  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional;
  • Engaged in conduct that is unbecoming of a member.

The Panel imposed an Order, as follows:

1. A reprimand.

2. Directing the Registrar to impose specified terms, conditions or limitations on the Member’s certificate of registration requiring that the Member successfully complete, within six (6) months of the date of the order, a course with Dr. Erika Abner, or another professional ethics consultant chosen by the College, to be designed by the consultant, regarding the issues raised by the facts and findings of professional misconduct in this case, and the following terms shall apply to the course:

a. the number of sessions shall be at the discretion of the consultant, but shall be a minimum of two (2) and a maximum of three (3) meetings;

b. the manner of attendance at the session(s) (e.g. in person, via Skype, etc.) is a matter to be discussed in advance between the Member and the consultant, but shall ultimately be at the discretion of the consultant;

c. the Member shall be responsible for the cost of the course;

d. the Member shall provide to the consultant the following documents, in advance of the course, to facilitate the design of the course:

i. the Notice of Hearing;

ii. the Agreed Statement of Facts;

iii. this Joint Submission on Order; and

iv. the Panel’s Decision and Reasons, if and when available;

e. successful completion of the course will include completion of an essay, acceptable to the Registrar, addressing the issues raised in this matter; and

f. the Member will request a report from the consultant confirming that the Member has completed the course to the satisfaction of the consultant, and the Member will provide a copy of the report to the College within six (6) months of the date of this Order.

3. Directing the Registrar to suspend the Member’s Certificate of Registration for a period of one (1) month, to be fully remitted on condition the Member complete the remedial training program specified in paragraph 2, above. If the suspension has to be served, it shall commence within six (6) months of the date of the order and continue without interruption for 30 days, inclusive, unless the time for completing the remedial steps in paragraph 2, above, is extended by the Registrar, in which case, the date the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $10,000.

In its reprimand, the Panel noted that pharmacy is a self-regulated profession. Pharmacists bear the responsibility of ensuring that the trust of members of the profession, and the public they serve, is maintained. The practice of pharmacy is a privilege, which carries with it significant obligations to the public, the profession, and oneself.

The Panel relayed its trust that this process will be a learning experience for Mr. Kim and cause him to reflect on his practice. The Panel expressed its expectation that Mr. Kim will never again appear before a panel of the discipline committee.


Mourcos Shenouda (OCP #612220)

At a hearing on October 7, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Mourcos Shenouda in that he billed for the weekly dispensing of medication in compliance aids to patients when he in fact dispensed in longer intervals to those patients, thereby charging a greater total dispensing fee than that to which he was entitled, and thereby maintaining inaccurate records of the dates on which drugs and/or products were dispensed, with respect to certain identified patients, from on or about June 27, 2017, to on or about July 4, 2019.

In particular, the Panel found that he:

READ MORE
  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients or practice;
  • Falsified a record related to his practice or a person’s health record;
  • Signed or issued in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional.

The Panel imposed an Order which included as follows:

1. A reprimand;

2. Directing the Registrar to impose specified terms, conditions or limitations on the Member’s certificate of registration requiring that the Member successfully complete, within six (6) months of the date of the order, a course with either Gail Siskind, Dr. Erika Abner, or another professional ethics consultant chosen by the College, to be designed by the consultant, regarding the issues raised by the facts and findings of professional misconduct in this case, and the following terms shall apply to the course:

a. the number of sessions shall be at the discretion of the consultant, but shall be a minimum of two (2) and a maximum of three (3) meetings;

b. the manner of attendance at the session(s) (e.g. in person, via Skype, etc.) is a matter to be discussed in advance between the Member and the consultant, but shall ultimately be at the discretion of the consultant;

c. the Member shall be responsible for the cost of the course;

d. the Member shall provide to the consultant the following documents, in advance of the course, to facilitate the design of the course:

i. the Notice of Hearing;

ii. the Agreed Statement of Facts;

iii. this Joint Submission on Order; and

iv. the Panel’s Decision and Reasons, if and when available;

e. successful completion of the course will include completion of an essay, acceptable to the Registrar, addressing the issues raised in this matter; and
the Member will request a report from the consultant confirming that the Member has completed the course to the satisfaction of the consultant, and the Member will provide a copy of the report to the College within six (6) months of the date of this Order.

3. Directing the Registrar suspend the Member’s Certificate of Registration for a period of three (3) months, with one (1) month of the suspension to be remitted on condition that the Member completes the remedial training as specified in paragraph 2(a), above. The suspension shall commence on the date of this Order and shall continue for two (2) months, without interruption. If the remitted portion of the suspension is required to be served by the Member because he fails to complete the remedial requirement specified in paragraph 2, that portion of the suspension shall commence on the date that is six (6) months from the date of this Order and shall continue for one (1) month, inclusive. If the time for completing the remedial steps in paragraph 2, above, is extended by the Registrar, the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $10,000.

In its reprimand, the Panel noted that pharmacy is a self-regulated profession. Pharmacists bear the responsibility to ensure that the trust of members, and the public they serve, is maintained. The practice of pharmacy is a privilege which carries significant obligations to the public, the profession, and oneself.

The Panel observed that, as a pharmacist, Mr. Shenouda is expected to meet his professional and ethical obligations. The Panel relayed that he failed in his responsibilities as a pharmacist and Designated Manager.

The Panel pointed out that it was Mr. Shenouda’s responsibility to practice in accordance with the law, and to have policies and procedures in place that comply with the law. Just because certain procedures and practices were put in place by the previous owner does not mean they should not be questioned or corrected if required.

The Panel expressed its trust that this disciplinary process will cause Mr. Shenouda to reflect on his practice and will motivate him to make positive changes, and that he will not appear before a panel of the Discipline Committee again.


Tiffany Czilli (OCP #606992)

At a hearing on October 21, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Tiffany Czilli in that she:

READ MORE
  • Submitted accounts or charges for services that she knew or reasonably ought to have known were false or misleading to the Ontario Drug Benefit program for MedsCheck reviews that were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
  • Falsified pharmacy records in relation to claims made to the Ontario Drug Benefit Program for MedsCheck reviews that were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or,
  • Failed to keep records as required in relation to MedsCheck claims made to the Ontario Drug Benefit Program.

In particular, the Panel found that she:

  • Failed to maintain a standard of practice of the profession;
  • Falsified records relating to her practice;
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading statement;
  • Contravened sections 20 and 21 of Ontario Regulation 264/16;
  • Failed to keep records as required;
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;

2. Directing the Registrar to impose specified terms, conditions or limitations on the Member’s Certificate of Registration, and in particular:

a. the Member must successfully complete with an unconditional pass, at her own expense and within eleven (11) months of the date that this Order becomes final, the ProBE Program offered by the Centre for Personalized Education for Physicians;

b. for a period of 3 years from the date that this Order becomes final, the Member is prohibited from:

i. acting as Designated Manager of any pharmacy; and

ii. having a proprietary interest in a pharmacy as a sole proprietor or partner, or director or shareholder in a corporation that owns a pharmacy, excepting only that she is permitted to own shares in a publicly traded company that has an interest in a pharmacy, or in any other capacity.

3. Directing the Registrar to suspend the Member’s Certificate for a period of twelve (12) months. The suspension will commence on October 21, 2020 and will run without interruption for eleven (11) months. If, by the end of the eleven months, the Member has completed the remedial training set out in paragraph 2(a) above, one (1) month of the suspension will be remitted. Otherwise, the Member will immediately serve the remaining month of the suspension.

4. Costs to the College in the amount of $35,000.

In its reprimand, the Panel expressed its extreme disappointment in Ms. Czilli’s behaviour as a pharmacist.

The Panel noted that pharmacists have an obligation to act in the best interest of the public, and that Ms. Czilli’s actions put the public at risk. The Panel indicated that this conduct is even more reprehensible as Ms. Czilli was acting as a workplace monitor for a vulnerable healthcare professional. Her misconduct has had a detrimental impact on pharmacists’ professional relationships with the public they serve.

The Panel related that the practice of pharmacy is a privilege, which carries with it significant obligations to the public, the profession, and oneself. The result of Ms. Czilli’s misconduct has eroded the public trust in the pharmacy profession and cast a shadow over her own integrity.

The Panel expressed its hope that this hearing has given Ms. Czilli the opportunity to pause for reflection and move forward, practicing pharmacy within the standards of the profession, and its expectation that she will not appear before a discipline panel again in the future.


Thi Vuong (OCP #90913)

At a hearing on October 27, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Thi Vuong in that she:

READ MORE
  • Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
  • Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
  • Falsified a record relating to her practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017; and/or
  • Submitted an account or charge for services that she knew or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017.

In particular, the Panel found that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients and/or practice;
  • Falsified a record relating to her practice and/or a person’s health record;
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act and section 20 of Ontario Regulation 264/16;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
    • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act and section 20 of Ontario Regulation 264/16;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional.

Ms. Vuong entered into an Acknowledgment and Undertaking, as part of the resolution of this matter, by which she agreed that she would permanently resign as a member of the College, and will no longer have, keep, or acquire any ownership interest in any pharmacy in Ontario, effective October 27, 2020.

The Panel imposed an Order which included as follows:

  1. A reprimand;
  2. Costs to the College in the amount of $12,000.

In its reprimand, the Panel noted that pharmacy is a self-regulated profession. All members of the profession have a responsibility to ensure that the public, including entities of the public such as drug plans, is adequately protected.

The Panel observed that members of the public hold pharmacists in very high regard. As a pharmacist and as a pharmacy owner, Ms. Vuong failed in her professional obligation to conduct herself in a manner that is respectable, responsible, and which maintains public confidence.

The Panel expressed its view that, as a result of her misconduct, Ms. Vuong let down the public, the pharmacy profession, and also herself. The Panel expressed its confidence that her decision to resign, and to not return to this profession, will ensure the public is protected.

The Panel noted that it is indeed unfortunate and disappointing that her lengthy career in this profession has come to a tainted end.


Abadir Nasr (OCP #218265)

At a hearing on October 28, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Abadir Nasr in that:

READ MORE
  • Between about January 9, 2013 and March 28, 2017, he failed to provide and/or update the Ontario College of Pharmacists with the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
  • Between about January 9, 2013 and March 28, 2017, he submitted annual renewal certificates and/or information to the College that were/was inaccurate with respect to the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
  • Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about June 2015 and December 2016, he provided and/or purported to provide routine pharmaceutical care to family members including [family members], and/or including himself as patient;
  • Between about June 2015 and December 2016, he signed certain identified prescription hardcopies as dispensing pharmacist, for ostensible prescriptions for family members including [family members], and/or including himself as patient, but that were not valid prescriptions;
  • Between about June 2015 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
  • Between about June 2015 and December 2016, he sold (or permitted, consented to or approved, expressly or impliedly, the sale of) certain identified prescription drugs and/or products without valid prescriptions;
  • Between about June 2015 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, the Panel found that he:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice;
  • Signed or issued in his professional capacity a document that he knew contained a false or misleading statement;
  • Submitted an account or charge for services that he knew was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

The Panel imposed an Order which included as follows:

1. A reprimand;

2. That the Registrar is directed to impose specified terms, conditions or limitations on the Member’s Certificate of Registration, and in particular:

a. that the Member complete successfully, with an unconditional pass, at his own expense and within twelve (12) months of the date of this Order, the ProBE Program on Professional/Problem Based Ethics offered by the Center for Personalized Education for Professionals;

b. that the Member successfully complete, within eighteen (18) months of the order, a course with Gail Siskind, expert in ethical issues for regulated health care professionals, or other expert acceptable to the College, following his successful completion of the remediation identified in paragraph 2(a), above. The following terms apply to a course with Ms. Siskind:

i. The number of sessions shall be at the discretion of the consultant, but shall be no fewer than 3.

ii. The manner of attendance at the session(s) (e.g. in person, via Skype, etc.) is a matter to be discussed in advance between the Member and the consultant, but shall ultimately be at the discretion of the consultant.

iii. The Member shall be responsible for the cost of the course.

iv. The Member shall provide to Ms. Siskind, in advance of the course, his essay and any and all evaluations from the ProBE Program;

v. The Member shall require Ms. Siskind to report the results of the course to the College no later than eighteen (18) months from the date of this order;

c. that the Member be prohibited

i. from acting as a Designated Manager for any pharmacy;

ii.from having any proprietary interest in a pharmacy as a sole proprietor or partner, or director or shareholder in a corporation that owns a pharmacy (excepting only that he/she may be permitted to own shares in a publicly traded corporation that has an interest in a pharmacy), or in any other capacity, and

iii. from receiving any remuneration for his/her work as a pharmacist, or related in any way to the operation of a pharmacy, other than remuneration based on hourly or weekly rates or salary and in particular, not on the basis of any incentive or bonus for prescription sales;

with such prohibitions to remain in effect for a minimum period of three (3) years from the date of this Order, and thereafter to remain in effect until removed by an Order of a panel of the Discipline Committee upon an application by the Member and upon the panel of the Discipline Committee being satisfied that it is appropriate that the prohibitions be removed;

3. That the Registrar suspend the Member’s Certificate of Registration for a period of fourteen (14) months, with one (1) month of the suspension to be remitted on condition that the Member complete the remedial training as specified in paragraphs 2(a) and 2(b). The suspension shall commence on October 28, 2020, and shall continue until November 27, 2021, inclusive. If the remitted portion of the suspension is required to be served by the Member because he fails to complete the remedial requirement specified in paragraphs 2(a) and/or 2(b), that portion of the suspension shall commence on November 28, 2021, and shall continue until December 27, 2021, inclusive. If the time for completing the remedial steps in paragraphs 2(a) and/or 2(b), above, is extended by the Registrar, the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $60,000.

The reprimand in this matter remains outstanding.


Nermin Iskandar (OCP #603693)

At a hearing on October 28, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Nermin Iskandar with respect to the following incidents:

READ MORE
  • Between about January 9, 2013 and March 28, 2017, she failed to actively and effectively participate in and/or monitor the day-to-day management of the Pharmacy, including, but not limited to drug procurement and inventory management, record keeping and documentation, billing, and staff and personnel management, and/or she failed to actively and effectively fulfill the duties and responsibilities of a Designated Manager;
  • Between about January 9, 2013 and March 28, 2017, she operated (or permitted, consented to or approved, expressly or impliedly, the operation of) the Pharmacy when it was not managed by a pharmacist who was designated as the Designated Manager of the Pharmacy;
  • Between about June 16, 2016 and March 28, 2017, she failed to ensure that her name, certificate of registration, or both were clearly and publicly displayed in the Pharmacy;
  • On or about January 9, 2013, she signed an Acknowledgment/Change of Designated Manager form containing a false or misleading statement by indicating that “[Name]” did not continue to work at the Pharmacy;
  • Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the provision of routine pharmaceutical care to family members including herself and/or one or more of [family members] by [Name] as dispensing pharmacist;
  • Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the selling of certain identified prescription drugs and/or products without valid prescriptions;
  • Between about June 2015 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
  • Between about June 2015 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, the Panel found that she:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to her practice;
  • Signed or issued in her professional capacity a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
    • s. 146(3) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
  • Permitted, consented to or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which she was a director;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;

2. That the Registrar is directed to impose specified terms, conditions or limitations on the Member’s Certificate of Registration, and in particular:

a. that the Member complete successfully, with an unconditional pass, at her own expense and within twelve (12) months of the date of this Order, the ProBE Program on Professional/Problem Based Ethics offered by the Center for Personalized Education for Professionals;

b. that the Member be prohibited, for a period of two years from the date of this Order, from acting as a Designated Manager for any pharmacy;

3. That the Registrar suspend the Member’s Certificate of Registration for a period of seven (7) months, with one (1) month of the suspension to be remitted on condition that the Member complete the remedial training as specified in paragraph 2(a). The suspension shall commence on October 28, 2020, and shall continue until April 27, 2021, inclusive. If the remitted portion of the suspension is required to be served by the Member because she fails to complete the remedial requirement specified in paragraph 2(a), that portion of the suspension shall commence on November 1, 2021, and shall continue until November 30, 2021, inclusive. If the time for completing the remedial steps in paragraph 2(a), above, is extended by the Registrar, the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.

4. Costs to the College in the amount of $12,000.

The reprimand in this matter remains outstanding.


The full text of these decisions is available at www.canlii.org.

CanLii is a non-profit organization managed by the Federation of Law Societies of Canada. CanLii’s goal is to make Canadian law accessible for free on the Internet.


Share this: